Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Vaccinology

Precisely tuned antibodies nab HIV

Nature volume 477, pages 416–417 (2011)Cite this article

Subjects

Newly discovered neutralizing antibodies that target sites on the envelope proteins of HIV-1 provide a window on how some of the most powerful of these antibodies acquire their potency and breadth of activity. See Letter p.466

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Spike-studded HIV-1.

References

  1. Pantophlet, R. & Burton, D. R. Annu. Rev. Immunol. 24, 739–769 (2006).

    Article  CAS  PubMed  Google Scholar 

  2. Walker, L. M. et al. Nature 477, 466–470 10.1038/nature10373 (2011).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  3. Scheid, J. F. et al. Science 333, 1633–1637 (2011).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wu, X. et al. Science 333, 1593–1602 (2011).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  5. Muster, T. et al. J. Virol. 67, 6642–6647 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Buchacher, A. et al. AIDS Res. Hum. Retroviruses 10, 359–369 (1994).

    Article  CAS  PubMed  Google Scholar 

  7. Barbas, C. F. III et al. Proc. Natl Acad. Sci. USA 91, 3809–3813 (1994).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  8. Corti, D. et al. PLoS ONE 5, e8805 (2010).

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  9. Wu, X. et al. Science 329, 856–861 (2010).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  10. Walker, L. M. et al. Science 326, 285–289 (2009).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  11. Bonsignori, M. et al. J. Virol. 85, 9998–10009; 10.1128/JVI.05045-11 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Scheid, J. F. et al. Nature 458, 636–640 (2009).

    Article  ADS  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Paul R. Clapham is in the Program in Molecular Medicine and Department of Microbiology and Physiological Systems, Worcester, Massachusetts 01605, USA.,

    Paul R. Clapham

  2. Shan Lu is in the Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA. S.L. is also at the China–US Vaccine Research Center, Nanjing Medical University.,

    Shan Lu

Authors
  1. Paul R. Clapham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shan Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Paul R. Clapham or Shan Lu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clapham, P., Lu, S. Precisely tuned antibodies nab HIV. Nature 477, 416–417 (2011). https://doi.org/10.1038/477416a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/477416a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research